Trial of intraventricular ribavirin therapy for subacute sclerosing panencephalitis in Japan.
D000293:Adolescent; D000328:Adult; D000963:Antimetabolites / Q000627:therapeutic use; D000998:Antiviral Agents / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use*; D002648:Child; D002675:Child, Preschool; D005260:Female; D006801:Humans; D007276:Injections, Intraventricular; D007564:Japan; D008297:Male; D012254:Ribavirin / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use*; D013344:Subacute Sclerosing Panencephalitis / Q000188:drug therapy*
D000963:Antimetabolites; D000998:Antiviral Agents; D012254:Ribavirin